Stockreport

Regenxbio raised to Buy at RBC on pivot to Duchenne [Seeking Alpha]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF Perform, arguing that the company's foray into Duchenne muscular dystrophy should drive further upside in its stock. The upgrade comes days after the Rockville, Maryla [Read more]